Second call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates in a mouse model
Diversification of the vaccine development pipeline has been identified as a priority area in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium aims, amongst other things, to fill the early phases of the development pipeline while ensuring a diverse portfolio (TBVAC-HORIZON – TBVI). One of the objectives of the project is to perform head-to-head […]
University of Oxford (UOXF) starts aligned clinical study – first participant enrolled
TBVAC-HORIZON has met an important milestone: On 3 April 2024, the first participant in the UOXF “TB46” study was enrolled. Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide, killing over 4,000 people every day. Prevention of TB infection by novel vaccines would provide the most cost-effective approach to achieve the goals of […]
7th Global Forum on TB vaccines – Call for abstracts
The Global Forum on TB Vaccines will take place from 8-10 October 2024 and will be hosted in Rio de Janeiro, Brazil. The Call for Abstracts for the 7th Global Forum on TB Vaccines is now available. Researchers, product developers, advocates, community representatives, and others engaged in new TB vaccines are encouraged to submit. Submissions […]
World Tuberculosis Day 2024 – We can End TB!
World Tuberculosis Day serves as a poignant reminder to raise awareness about tuberculosis (TB). Despite the efforts and promising developments in the fight against this disease, TB remains an endemic that leads to 1.3 million deaths each year. 24 March 2024 Innovations in medical science and public health strategies have provided powerful tools in the […]
MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India.
MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human, reaches a new milestone by starting clinical trials in India, the most populated country in the world and the one with the highest number of cases of this infectious disease. Please read the press release for more information: Spanish […]
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate
The Bill & Melinda Gates Medical Research Institute (Gates MRI) today (19 March 2024) announced that a Phase 3 clinical trial to assess the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, where TB takes a heavy toll. If shown to be well-tolerated and effective, […]
TBVI announces the appointment of its new Executive Director
March 2024 – The TBVI Governance Board is pleased to announce the appointment of a new Executive Director of the organisation. Tuberculosis (TB) stands as one of the most persistent and formidable infectious diseases, exerting a substantial burden on global health. Despite progress in healthcare, TB remains a leading cause of morbidity and mortality, particularly in […]
Les Diablerets 2024 (presentations are now available)
On January 30-31, 2024, the TBVI Symposium was held in Les Diablerets, Switzerland. This year, the symposium brought together over 120 tuberculosis (TB) vaccine researchers, developers, funders and policymakers that are all part of TBVI’s network of over 60 research institutes, universities, industrial partners and funding agencies from 20 countries. To encourage synergy and knowledge […]
May the New Year bring you renewed hope, good health and happiness
The TBVI team wishes you and your loved ones a joyful holiday season. May the New Year bring you renewed hope, good health and happiness. We want to express our heartfelt gratitude to all our partners. Together, we are committed to eliminating the burden of TB worldwide by our shared creativity, endurance and the […]
Announcement awardees of the TBVI Young Scientist Award 2023-2024
To encourage talented young scientists and recognise outstanding contributions to TB vaccine research and development, in October TBVI published the TBVI Young Scientist Awards 2024. It is our pleasure to announce the three winners of the 2023-2024 award: Paul OgongoPaul grew up in Kenya where he got his bachelor’s and master’s degrees. In 2019 […]